PHARMACOKINETICS OF N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE IN PATIENTS WITH ACUTE-LEUKEMIA

被引：0
作者：
UEDA, T
NAKAMURA, T
ANDO, S
KAGAWA, D
SASADA, M
UCHINO, H
JOHNO, I
AKIYAMA, Y
机构：
[1] KYOTO UNIV,FAC MED,DEPT PHARM,KYOTO 606,JAPAN
[2] KYOTO UNIV,FAC MED,DEPT PEDIAT,KYOTO 606,JAPAN
[3] FUKUI MED SCH,DEPT MED,MATSUOKA,FUKUI 91011,JAPAN
来源：
CANCER RESEARCH | 1983年 / 43卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3412 / 3416
页数：5
相关论文
共 50 条
  • [21] MODULATION OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE METABOLISM BY THYMIDINE IN HUMAN ACUTE-LEUKEMIA
    ZITTOUN, R
    ZITTOUN, J
    MARQUET, J
    RUSTUM, Y
    CREAVEN, P
    [J]. CANCER RESEARCH, 1985, 45 (10) : 5186 - 5192
  • [22] INTRACELLULAR PHARMACOKINETICS OF N4-BEHENOYL-1-BETA-D-ARABINO-FURANOSYLCYTOSINE
    HIGASHIGAWA, M
    HORI, H
    OCHIAI, H
    OHKUBO, T
    KAWASAKI, H
    NOBORI, T
    KAMIYA, H
    SAKURAI, M
    [J]. PURINE AND PYRIMIDINE METABOLISM IN MAN VI, PT B: BASIC RESEARCH AND EXPERIMENTAL BIOLOGY, 1989, 253 : 341 - 348
  • [23] 4-DEMETHOXYDAUNORUBICIN (IDARUBICIN) IN COMBINATION WITH 1-BETA-D-ARABINOFURANOSYLCYTOSINE IN THE TREATMENT OF RELAPSED OR REFRACTORY ACUTE-LEUKEMIA
    BERMAN, E
    RAYMOND, V
    DAGHESTANI, A
    ARLIN, ZA
    GEE, TS
    KEMPIN, S
    HANCOCK, C
    WILLIAMS, L
    STEVENS, YW
    CLARKSON, BD
    YOUNG, C
    [J]. CANCER RESEARCH, 1989, 49 (02) : 477 - 481
  • [24] INVIVO DISTRIBUTION OF C-14-LABELED N4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE IN MICE
    TOYOSHIMA, S
    FUKUMA, M
    SETO, Y
    FUJITA, H
    FUKUSHIMA, K
    TOMIOKA, H
    SAKURAI, T
    SUGIMOTO, Y
    YAGI, T
    HOSHINO, T
    SOWA, T
    [J]. GANN, 1981, 72 (01): : 19 - 29
  • [25] BIOCHEMICAL PHARMACOLOGY OF HIGH-DOSE 1-BETA-D-ARABINOFURANOSYLCYTOSINE IN CHILDHOOD ACUTE-LEUKEMIA
    AVRAMIS, VI
    BIENER, R
    KRAILO, M
    FINKLESTEIN, J
    ETTINGER, L
    WILLOUGHBY, M
    SIEGEL, SE
    HOLCENBERG, JS
    [J]. CANCER RESEARCH, 1987, 47 (24) : 6786 - 6792
  • [26] Close correlation of 1-β-D-arabinofuranosylcytosine 5′-triphosphate, an intracellular active metabolite, to the therapeutic efficacy of N4-behenoyl-1-β-D-arabinofuranosylcytosine therapy for acute myelogenous leukemia
    Yamauchi, T
    Kawai, Y
    Goto, N
    Kishi, S
    Imamura, S
    Yoshida, A
    Urasaki, Y
    Fukushima, T
    Iwasaki, H
    Tsutani, H
    Masada, M
    Ueda, T
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 2001, 92 (09): : 975 - 982
  • [27] TREATMENT OF ACUTE NONLYMPHOCYTIC LEUKEMIA BY CONCURRENT ADMINISTRATION OF N-4-BEHENOYL-L-BETA-D-ARABINOFURANOSYLCYTOSINE, ACLACINOMYCIN-A, 6-MERCAPTOPURINE AND PREDNISOLONE - A PILOT-STUDY
    HIRANO, M
    MORISHITA, Y
    INO, T
    MATSUI, T
    SHIMIZU, S
    SHIGEMURA, H
    NAKAMURA, K
    ONO, Y
    SAITO, M
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1981, 11 (01) : 87 - 92
  • [28] PHARMACOKINETICS OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE IN HUMANS
    WAN, SH
    HUFFMAN, DH
    AZARNOFF, DL
    HOOGSTRATEN, B
    LARSEN, WE
    [J]. CANCER RESEARCH, 1974, 34 (02) : 392 - 397
  • [29] INVIVO CELLULAR KINETIC AND PHARMACOLOGICAL STUDIES OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE AND 3-DEAZAURIDINE CHEMOTHERAPY FOR RELAPSING ACUTE-LEUKEMIA
    BARLOGIE, B
    PLUNKETT, W
    RABER, M
    LATREILLE, J
    KEATING, M
    MCCREDIE, K
    [J]. CANCER RESEARCH, 1981, 41 (03) : 1227 - 1235
  • [30] PHARMACOKINETIC STUDIES OF INTERMEDIATE-DOSE TO HIGH-DOSE 1-BETA-D-ARABINOFURANOSYLCYTOSINE IN CHILDREN WITH ACUTE-LEUKEMIA AND LYMPHOMA
    TAKASHIMA, Y
    MATSUYAMA, K
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 27 (04) : 330 - 333
12345